![Figure 3: STRO-001 showed potent cell killing activity on proliferating primary human B cells.](https://www.oncotarget.net/wp-content/uploads/2023/01/Screen-Shot-2023-01-17-at-2.09.03-PM-300x170.png)
Oncotarget | Targeting CD74 in B-cell Non-Hodgkin Lymphoma With Antibody-Drug Conjugate STRO-001
January 17, 2023
Taken together, these findings provide a strong rationale for potently and selectively targeting of CD74 in patients with B-NHL [B-cell non-Hodgkin lymphoma].” BUFFALO, NY- January 17, 2023 – A new... read more